Notice Type
Notice Title

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:


Active Ingredient:
Dosage Form:
New Zealand Sponsor:

Agalsidase alfa 1mg/mL
Concentrate for infusion
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Cangene bioPharma, Maryland, United States of America
Vetter Pharma-Fertigung GmbH & Co KG, Langenargen, Germany

Dated this 24th day of October 2015.

CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).